USPTO trademark

HYNTRELTA

RegisteredUSPTOWord markClass 5

"HYNTRELTA" is a word mark owned by Glaxo Group Limited, filed at the USPTO on January 24, 2022. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
HYNTRELTA trademark as filed
As filed with the USPTO
Status
Registered
Since January 17, 2023
Filed
January 24, 2022
Registered
January 17, 2023
Expires
Not recorded
Application no.
97235533
Registration no.
6957295
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns HYNTRELTA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

GlaxoSmithKline

Goods and services

What the mark covers

The products and services HYNTRELTA is filed for, grouped by Nice class.

  • Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Applicant/correspondence changes (non-responsive) entered
  5. Teas change of owner address received
  6. Notice of registration confirmation emailed
  7. Registered-principal register
  8. Teas change of correspondence received
  9. Attorney/dom.rep.revoked and/or appointed
  10. Teas revoke/app/change addr of atty/dom rep received

7 earlier steps on the official record.

FAQ

About HYNTRELTA

Who owns the trademark "HYNTRELTA"?

The USPTO trademark "HYNTRELTA" (application 97235533) is owned by Glaxo Group Limited.

What is the status of "HYNTRELTA"?

Its status at the USPTO is: registered.

When was "HYNTRELTA" registered?

It was registered on January 17, 2023.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull HYNTRELTA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a20-3af5-70ec-be7c-b4433d5b30cb
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a20-3af5-70ec-be7c-b4433d5b30cb",
  "object": "trademark",
  "mark_text": "HYNTRELTA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97235533",
  "filing_date": "2022-01-24",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}